Tirzepatide

GLP-1/GIP Receptor Agonist

Dual GLP-1 and GIP receptor agonist for weight management and type 2 diabetes. Removed from FDA shortage list Oct 2024.

Injectable (subcutaneous)

Pharmacies Carrying Tirzepatide